News

 

Paper published on the impact of HPV status

In a paper led by Alex Whitmarsh arising from our collaboration with colleagues at the German Cancer Research Centre (DKFZ) we examined the impact of HPV status on survival in people with oropharyngeal cancer. We found that HPV status confers a survival advantage across all groups. Furthermore, this survival advantage is more marked in younger people with oropharyngeal cancer but the survival advantage does not vary by gender, smoking status or site. We also found that the HPV antibody pattern, but not the antibody level, may also affect survival. The paper has been published in Cancer. (Epub ahead of print).

 

HEADSpAcE and VOYAGER meetings

We attended two virtual annual half day meetings for our ongoing HEADSpAcE and VOYAGER projects and a half day combined scientific meeting on the week beginning the 8th March. The meetings were well attended and it was great to catch up with colleagues and discuss progress (albeit on line). Hopefully face to face meetings will be possible in the not too distant future.

 

Paper on inequality in survival of people with head and neck cancer has been published

Kate Ingarfield, who used to work as the Head & Neck 5000 study statistician, has led on a paper looking at survival and socioeconomic status in head and neck cancer. The results support interventions to address financial issues within the wider care and support provided to head and neck cancer patients.

The paper has been published in the Head and Neck journal online ahead of print. Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study  Head and Neck  2021 Jan 8. doi: 10.1002/hed.26589.